The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today announced a new report that addresses the challenges in defining the clinical utility ...
Aug 17, 2016
0
0
The Association for Molecular Pathology (AMP) today announced the results from a 2015 analysis of the costs and health economic impact of several Current Procedural Terminology (CPT) genomic sequencing procedures (GSPs). ...
Apr 13, 2016
0
0
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, has updated its pathology residency curriculum recommendations for 10 critical molecular ...
Feb 5, 2016
0
0
The outcomes of chronic myeloid leukemia (CML) have dramatically improved as the result of tyrosine kinase inhibitor (TKI) treatment. Use of a TKI regimen can lower the blood CML biomarker to levels imperceptible by current ...
Feb 5, 2016
0
155
Cystic fibrosis (CF) occurs less frequently in nonwhites than in whites, and nonwhites tend to be diagnosed at a later age. This late diagnosis often comes only once they have become symptomatic, rather than through newborn ...
Dec 16, 2015
0
36
It's a wonder of modern science that, for at least some types of cancer, doctors are now able to exploit the unique genetic faults in a person's tumour to treat their disease with precision drugs.
Aug 20, 2015
0
4
The Association for Molecular Pathology (AMP) today published a special article in The Journal of Molecular Diagnostics titled, "Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility?" ...
Apr 22, 2015
0
8
The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) are teaming to revise the evidence-based guideline, "Molecular ...
Jan 12, 2015
0
87
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals, announced the release of an important white paper addressing the consequences of regulatory ...
Jan 8, 2015
0
6
One of the roadblocks to the eradication of tuberculosis (TB) is the difficulty in identifying patients with latent TB infections (LTBI). Neither the tuberculin skin test (TST) nor interferon-gamma release assays (IGRAs) ...
Jan 6, 2015
0
9
